IndraLab

Statements


MYSM1 inhibits PI3K. 2 / 2
| 2

reach
"MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling."

reach
"Furthermore, silencing MYSM1 stimulated PI3K/AKT signaling and promoted EMT in CRC cells."